Clinical Presentations, Risk Factors and Outcomes of Cryptococcal Meningitis Among Patients Diagnosed with HIV/AIDS, Attending Clinic at Bugando Medical Centre, Mwanza, Tanzania.
Material type:
TextPublisher number: Wurzburg Road 35, Premises, Post Code: 33102 | P. O. Box 1464 Mwanza, Tanzania | Phone: (255) 28-298-3384 | Fax: (255) 28-298-3386 | Email: vc@bugando.ac.tz | Website: www.bugando.ac.tz. Language: English Language: Kiswahili Publication details: Mwanza, Tanzania | Catholic University of Health and Allied Sciences [CUHAS-Bugando] | 2024.Description: 35 Pages; Includes ReferencesSubject(s): Summary: Abstract:
Background: Cryptococcal meningitis is the most common lethal fungal infection in patients with HIV/AIDS worldwide. It accounts for more than 22% of HIV/AIDS-related mortality in Africa. Therefore, screening and early anti-fungal treatment are important for reducing deaths caused by Cryptococcal meningitis. We conducted research to provide updated information regarding Cryptococcal meningitis following initiation of prophylactic medications.
Method: A retrospective cross-sectional hospital-based study was done among newly diagnosed patients with HIV/AIDS aged >18 years who attend clinic at BMC. Sociodemographic and clinical information were collected using a structured checklist
Results: Among 141 patients who were diagnosed with HIV/AIDS only 4(2.84%) were diagnosed with CM. All patients diagnosed with CM were female, had CD4 cell count of <200cells/mm3 and had poor adherence to ART.
Conclusion: This study reports low prevalence of CM among patients diagnosed with HIV/AIDS at BMC but there is high CM associated mortality, even with use of Amphotericin B based therapy, fluconazole and Flucytosine. Therefore, there is a need of evaluating and reviewing the treatment guidelines used at our clinical setting to help reduce the mortality.
| Item type | Current library | Status | Barcode | |
|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | Not for loan | 20240903104914.0 |
Abstract:
Background: Cryptococcal meningitis is the most common lethal fungal infection in patients with HIV/AIDS worldwide. It accounts for more than 22% of HIV/AIDS-related mortality in Africa. Therefore, screening and early anti-fungal treatment are important for reducing deaths caused by Cryptococcal meningitis. We conducted research to provide updated information regarding Cryptococcal meningitis following initiation of prophylactic medications.
Method: A retrospective cross-sectional hospital-based study was done among newly diagnosed patients with HIV/AIDS aged >18 years who attend clinic at BMC. Sociodemographic and clinical information were collected using a structured checklist
Results: Among 141 patients who were diagnosed with HIV/AIDS only 4(2.84%) were diagnosed with CM. All patients diagnosed with CM were female, had CD4 cell count of <200cells/mm3 and had poor adherence to ART.
Conclusion: This study reports low prevalence of CM among patients diagnosed with HIV/AIDS at BMC but there is high CM associated mortality, even with use of Amphotericin B based therapy, fluconazole and Flucytosine. Therefore, there is a need of evaluating and reviewing the treatment guidelines used at our clinical setting to help reduce the mortality.
There are no comments on this title.
Click on an image to view it in the image viewer